Zhi Yang

Title: Zhi Yang: Innovator in Hematopoiesis Research

Introduction

Zhi Yang is a notable inventor based in Palo Alto, CA, who has made significant contributions to the field of hematopoiesis through his innovative research and patents. With a total of 4 patents to his name, Yang's work focuses on the development of proteins and antibodies that have important applications in medical diagnostics and therapeutics.

Latest Patents

Yang's latest patents include a purified soluble form of Flk-2, which is provided as both a DNA sequence and a protein. This invention is crucial for modulating hematopoiesis in culture and in vivo, as well as for producing antibodies for assays of the proteins. Another significant patent involves receptors for advanced glycosylation end products derived from rat liver membranes. These receptors, which possess molecular masses of about 90 kD and 60 kD, are essential for developing diagnostic and therapeutic agents.

Career Highlights

Throughout his career, Zhi Yang has worked with prestigious institutions such as The Rockefeller University and Systemix, Inc. His research has led to advancements in understanding the mechanisms of hematopoiesis and the development of related therapeutic agents.

Collaborations

Yang has collaborated with esteemed colleagues, including Helen Vlassara and Anthony Cerami, further enhancing the impact of his research in the scientific community.

Conclusion

Zhi Yang's contributions to the field of hematopoiesis through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and therapeutic applications.